Related Experiment Video
Updated: Jul 16, 2025

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2)
Clodagh Towns1, Madeleine Richer1, Simona Jasaityte1
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK.
Abstract:
The Global Parkinson's Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow for cohort integration into the complex arm of GP2, and together with our outline of the monogenic hub in a companion paper, provides a generalizable blueprint for establishing large scale collaborative research consortia.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Parkinson's Disease: Overview
Single Nucleotide Polymorphisms-SNPs
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

